271 related articles for article (PubMed ID: 12586300)
21. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
22. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
Zaloumis SG; Allen KJ; Bertalli NA; Turkovic L; Delatycki MB; Nicoll AJ; McLaren CE; English DR; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
J Gastroenterol Hepatol; 2015 Apr; 30(4):719-25. PubMed ID: 25311314
[TBL] [Abstract][Full Text] [Related]
23. [Mutations in the HFE gene (C282Y, H63D, S65C) in alcoholic patients with finding of iron overload].
Campos Franco J; González Quintela A; Fernández de Trocóniz LL; Barros Angueira F; Pérez-Quintela BV; Pérez Becerra E; Martínez de Rituerto ST; Otero Antón E; Torre Carballada JA
Rev Clin Esp; 2002 Oct; 202(10):534-9. PubMed ID: 12361551
[TBL] [Abstract][Full Text] [Related]
24. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
[TBL] [Abstract][Full Text] [Related]
25. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy.
Cassanelli S; Pignatti E; Montosi G; Garuti C; Mariano M; Campioli D; Carbonieri A; Baldini E; Pietrangelo A
J Hepatol; 2001 Apr; 34(4):523-8. PubMed ID: 11394651
[TBL] [Abstract][Full Text] [Related]
26. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
[TBL] [Abstract][Full Text] [Related]
27. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.
Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685
[TBL] [Abstract][Full Text] [Related]
28. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.
Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Lonjon I; Bastie A; Duvoux C; Pawlotsky JM; Zafrani ES; Amselem S; Dhumeaux D
J Hepatol; 1999 Dec; 31(6):979-84. PubMed ID: 10604569
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.
Barton JC; Barton JC; Adams PC
Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
[TBL] [Abstract][Full Text] [Related]
31. HFE haemochromatosis gene mutations in liver transplant patients.
Halme L; Heliö T; Mäkinen J; Höckerstedt K; Färkkilä M; Piippo K; Krusius T; Kontula K
Scand J Gastroenterol; 2001 Aug; 36(8):881-5. PubMed ID: 11495086
[TBL] [Abstract][Full Text] [Related]
32. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
33. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH
Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
[TBL] [Abstract][Full Text] [Related]
34. [Iron as comorbid factor in chronic hepatitis C].
Erhardt A; Hauck K; Häussinger D
Med Klin (Munich); 2003 Dec; 98(12):685-91. PubMed ID: 14685669
[TBL] [Abstract][Full Text] [Related]
35. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations?
Sikorska K; Stalke P; Jaskiewicz K; Romanowski T; Bielawski KP
Hepatogastroenterology; 2008; 55(84):1024-8. PubMed ID: 18705322
[TBL] [Abstract][Full Text] [Related]
36. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
[TBL] [Abstract][Full Text] [Related]
37. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.
Nelson JE; Bhattacharya R; Lindor KD; Chalasani N; Raaka S; Heathcote EJ; Miskovsky E; Shaffer E; Rulyak SJ; Kowdley KV
Hepatology; 2007 Sep; 46(3):723-9. PubMed ID: 17680648
[TBL] [Abstract][Full Text] [Related]
38. Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y.
Wallace DF; Walker AP; Pietrangelo A; Clare M; Bomford AB; Dixon JL; Powell LW; Subramaniam VN; Dooley JS
J Hepatol; 2002 Apr; 36(4):474-9. PubMed ID: 11943417
[TBL] [Abstract][Full Text] [Related]
39. The H63D mutation of the hemochromatosis gene is associated with sustained virological response in chronic hepatitis C patients treated with interferon-based therapy: a meta-analysis.
Li SH; Zhao H; Ren YY; Liu YZ; Song G; Ding P; Ding YP; Wang GQ
Tohoku J Exp Med; 2012 Apr; 226(4):293-9. PubMed ID: 22499121
[TBL] [Abstract][Full Text] [Related]
40. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
Bonkovsky HL; Troy N; McNeal K; Banner BF; Sharma A; Obando J; Mehta S; Koff RS; Liu Q; Hsieh CC
J Hepatol; 2002 Dec; 37(6):848-54. PubMed ID: 12445428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
